Published in

American Society of Hematology, Blood Advances, 23(3), p. 3962-3967, 2019

DOI: 10.1182/bloodadvances.2019000731

Links

Tools

Export citation

Search in Google Scholar

Stem cell mutations can be detected in myeloma patients years before onset of secondary leukemias

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Red circle
Preprint: archiving forbidden
Red circle
Postprint: archiving forbidden
Green circle
Published version: archiving allowed
Data provided by SHERPA/RoMEO

Abstract

Key Points Leukemia-associated mutations can be detected many years before the onset of secondary leukemias in myeloma patients. Stem and progenitor cells can act as reservoirs of mutations before the onset of secondary MDS and AML after treatment of myeloma.